IPO Subscription Status
The public issue Zenith Drugs was subscribed 106.72x for Qualified Institutional Buyers (QIBs), 369.93x for Non Institutional Investors (NIIs), 138.46x for Retail, 179.01x for Total,
| Investor Category | Shares Offered | Shares Bid For | Subscription Times | Total Amount |
|---|---|---|---|---|
| Qualified Institutional Buyers (QIBs) | 859,200 | 91,697,600 | 106.72 | 724.41 |
| Non Institutional Investors (NIIs) | 644,800 | 238,529,600 | 369.93 | 1,884.38 |
| Retail | 1,504,000 | 208,248,000 | 138.46 | 1,645.16 |
| Total | 3,008,000 | 538,475,200 | 179.01 | 4,253.95 |
This table provides information about the subscription details of Zenith Drugs for different investor categories: Qualified Institutional Buyers (QIBs), Non-Institutional Investors (NIIs), Retail, and the overall Total, in the context of a securities offering or initial public offering (IPO).
IPO Day-wise Subscription Details
The following table presents the IPO day-wise subscription details forZenith Drugs across various investor categories, including Qualified Institutional Buyers (QIBs), Non-Institutional Investors (NIIs), Retail, and the overall Total. The information is organized to showcase the subscription figures on specific dates during the initial public offering.
| Date | QIB | NII | Retail | Total |
|---|---|---|---|---|
| 19 Feb 24 | - | 0.95 | 3.28 | 1.84 |
| 20 Feb 24 | 3.53 | 3.79 | 9.22 | 6.43 |
| 21 Feb 24 | 3.54 | 9.25 | 18.99 | 12.49 |
| 22 Feb 24 | 106.72 | 369.93 | 138.46 | 179.01 |